EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mGem: How many fungal secondary metabolites are produced by filamentous fungi? Conservatively, at least 1.4 million

Olivia L Riedling iD, Antonis Rokas iD

mBio · 08.10.2025 · 16 (10)

DOI: 10.1128/mbio.01381-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 08.10.2025. Verfasst von Olivia L Riedling und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Secondary Metabolism, Ascomycota, Fungi, Biosynthetic Pathways. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Science Foundation, Burroughs Wellcome Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ~30,000 known fungal secondary metabolites (SMs) are a vital component of the bioeconomy. SMs are biosynthesized by biosynthetic gene clusters (BGCs), i.e., sets of genes in close physical proximity in the genome. The bulk of these SMs are produced by filamentous fungi in the Pezizomycotina subphylum (phylum Ascomycota). To gauge the magnitude of chemodiversity in this subphylum, we utilized data from the well-characterized genus Aspergillus and a previous Pezizomycotina genomic survey. With 30–50 BGCs per genome, our rarefaction analyses show that the ~85,000 known species in Pezizomycotina likely contain 1.4–4.3 million SMs from an estimated 870 thousand to 2.7 million gene cluster families. Considering that only 5% of fungal species have been described and that the actual number of Pezizomycotina species is likely closer to a million, the projected number of SMs is likely between ~16 and 50 million. These estimates suggest that most fungal SMs remain undiscovered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Secondary MetabolismAscomycotaFungiBiosynthetic PathwaysMultigene FamilyGenome, FungalAspergillus

Stichwörter der Autor:innen

Aspergillusbiosynthetic gene clustersdiversityfunginatural productspezizomycotinasecondary metabolitesspecialized metabolites

Autor:innen und Institutionen

  • Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee, USA.
  • Evolutionary Studies Initiative, Vanderbilt University, Nashville, Tennessee, USA.

ORCID-Profile: Olivia L Riedling, Antonis Rokas

Förderung

  • NIAID NIH HHS
  • National Science Foundation
  • Burroughs Wellcome Fund
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Riedling, O. L., & Rokas, A. (2025). mGem: How many fungal secondary metabolites are produced by filamentous fungi? Conservatively, at least 1.4 million. mBio, 16(10). https://doi.org/10.1128/mbio.01381-25

Vancouver

Riedling OL, Rokas A. mGem: How many fungal secondary metabolites are produced by filamentous fungi? Conservatively, at least 1.4 million. mBio. 2025;16(10). doi:10.1128/mbio.01381-25

BibTeX
@article{Riedling2025,
  author = {Riedling, Olivia L and Rokas, Antonis},
  title = {mGem: How many fungal secondary metabolites are produced by filamentous fungi? Conservatively, at least 1.4 million},
  journal = {mBio},
  year = {2025},
  volume = {16},
  number = {10},
  doi = {10.1128/mbio.01381-25}
}
Kostenlos starten →